HEADER NUCLEOTIDYLTRANSFERASE 25-JUL-94 3HVT TITLE STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE TITLE 2 1 REVERSE TRANSCRIPTASE HETERODIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66); COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.7.49; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P51); COMPND 8 CHAIN: B; COMPND 9 EC: 2.7.7.49; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 6 ORGANISM_TAXID: 11676 KEYWDS NUCLEOTIDYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.A.STEITZ,S.J.SMERDON,J.JAEGER,J.WANG,L.A.KOHLSTAEDT,A.J.CHIRINO, AUTHOR 2 J.M.FRIEDMAN,P.A.RICE REVDAT 4 21-FEB-24 3HVT 1 REMARK REVDAT 3 24-FEB-09 3HVT 1 VERSN REVDAT 2 01-APR-03 3HVT 1 JRNL REVDAT 1 15-OCT-94 3HVT 0 SPRSDE 15-OCT-94 3HVT 2HVT JRNL AUTH S.J.SMERDON,J.JAGER,J.WANG,L.A.KOHLSTAEDT,A.J.CHIRINO, JRNL AUTH 2 J.M.FRIEDMAN,P.A.RICE,T.A.STEITZ JRNL TITL STRUCTURE OF THE BINDING SITE FOR NONNUCLEOSIDE INHIBITORS JRNL TITL 2 OF THE REVERSE TRANSCRIPTASE OF HUMAN IMMUNODEFICIENCY VIRUS JRNL TITL 3 TYPE 1. JRNL REF PROC.NATL.ACAD.SCI.USA V. 91 3911 1994 JRNL REFN ISSN 0027-8424 JRNL PMID 7513427 JRNL DOI 10.1073/PNAS.91.9.3911 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.JAEGER,S.J.SMERDON,J.WANG,D.C.BOISVERT,T.A.STEITZ REMARK 1 TITL COMPARISON OF THREE DIFFERENT CRYSTAL FORMS SHOWS HIV-1 REMARK 1 TITL 2 REVERSE TRANSCRIPTASE DISPLAYS AN INTERNAL SWIVEL MOTION REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH S.J.SMERDON,J.JAEGER,J.WANG,L.A.KOHLSTAEDT,A.J.CHIRINO, REMARK 1 AUTH 2 J.FRIEDMAN,P.A.RICE,T.A.STEITZ REMARK 1 TITL STRUCTURE OF THE BINDING SITE FOR NONNUCLEOSIDE INHIBITORS REMARK 1 TITL 2 OF THE REVERSE TRANSCRIPTASE OF HUMAN IMMUNODEFICIENCY VIRUS REMARK 1 TITL 3 TYPE 1 REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 91 3911 1994 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.A.STEITZ,S.J.SMERDON,J.JAEGER,J.WANG,L.A.KOHLSTAEDT, REMARK 1 AUTH 2 J.FRIEDMAN,L.BEESE,P.A.RICE REMARK 1 TITL TWO DNA POLYMERASES: HIV REVERSE TRANSCRIPTASE AND KLENOW REMARK 1 TITL 2 FRAGMENT OF E. COLI DNA POLYMERASE I. (IN: DNA & REMARK 1 TITL 3 CHROMOSOMES: ABSTRACTS OF PAPERS PRESENTED AT THE LVIII COLD REMARK 1 TITL 4 SPRING HARBOR SYMPOSIUM ON QUANTITATIVE BIOLOGY) REMARK 1 REF COLD SPRING HARBOR V. 58 495 1993 REMARK 1 REF 2 SYMP.QUANT.BIOL. REMARK 1 REFN ISSN 0091-7451 REMARK 1 REFERENCE 4 REMARK 1 AUTH L.A.KOHLSTAEDT,J.WANG,J.M.FRIEDMAN,P.A.RICE,T.A.STEITZ REMARK 1 TITL CRYSTAL STRUCTURE AT 3.5 ANGSTROMS RESOLUTION OF HIV-1 REMARK 1 TITL 2 REVERSE TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR REMARK 1 REF SCIENCE V. 256 1783 1992 REMARK 1 REFN ISSN 0036-8075 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 31265 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.266 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7406 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 BOND ANGLES (DEGREES) : 2.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3HVT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000179011. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 111.80000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.95000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 111.80000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.95000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 1 REMARK 465 PRO B 1 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 465 TYR B 232 REMARK 465 GLU B 233 REMARK 465 LEU B 234 REMARK 465 HIS B 235 REMARK 465 PRO B 236 REMARK 465 ASP B 237 REMARK 465 LYS B 238 REMARK 465 TRP B 239 REMARK 465 THR B 240 REMARK 465 VAL B 241 REMARK 465 GLN B 242 REMARK 465 PRO B 243 REMARK 465 ILE B 244 REMARK 465 VAL B 245 REMARK 465 LEU B 246 REMARK 465 PRO B 247 REMARK 465 GLU B 248 REMARK 465 LYS B 249 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 HIS B 361 REMARK 465 THR B 362 REMARK 465 ASN B 363 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 63 CG1 CG2 CD1 REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 LYS A 65 CG CD CE NZ REMARK 470 LYS A 66 CG CD CE NZ REMARK 470 ASP A 67 CG OD1 OD2 REMARK 470 SER A 68 OG REMARK 470 TYR A 115 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 PHE A 116 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 134 OG REMARK 470 ILE A 135 CG1 CG2 CD1 REMARK 470 ASN A 136 CG OD1 ND2 REMARK 470 ASN A 137 CG OD1 ND2 REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 THR A 139 OG1 CG2 REMARK 470 ASP A 218 CG OD1 OD2 REMARK 470 LYS A 219 CG CD CE NZ REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 HIS A 221 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 222 CG CD OE1 NE2 REMARK 470 LYS A 223 CG CD CE NZ REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 THR A 290 OG1 CG2 REMARK 470 GLU A 291 CG CD OE1 OE2 REMARK 470 VAL A 292 CG1 CG2 REMARK 470 ILE A 293 CG1 CG2 CD1 REMARK 470 GLU A 298 CG CD OE1 OE2 REMARK 470 GLU A 300 CG CD OE1 OE2 REMARK 470 LEU A 301 CG CD1 CD2 REMARK 470 GLU A 302 CG CD OE1 OE2 REMARK 470 LEU A 303 CG CD1 CD2 REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 ASN A 306 CG OD1 ND2 REMARK 470 ARG A 307 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 308 CG CD OE1 OE2 REMARK 470 ILE A 309 CG1 CG2 CD1 REMARK 470 LEU A 310 CG CD1 CD2 REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 GLU A 312 CG CD OE1 OE2 REMARK 470 PRO A 313 CG CD REMARK 470 VAL A 314 CG1 CG2 REMARK 470 HIS A 315 CG ND1 CD2 CE1 NE2 REMARK 470 VAL A 317 CG1 CG2 REMARK 470 LYS A 323 CG CD CE NZ REMARK 470 ASP A 324 CG OD1 OD2 REMARK 470 LEU A 325 CG CD1 CD2 REMARK 470 ILE A 326 CG1 CG2 CD1 REMARK 470 GLU A 328 CG CD OE1 OE2 REMARK 470 ILE A 329 CG1 CG2 CD1 REMARK 470 GLN A 330 CG CD OE1 NE2 REMARK 470 LYS A 331 CG CD CE NZ REMARK 470 GLN A 332 CG CD OE1 NE2 REMARK 470 GLN A 334 CG CD OE1 NE2 REMARK 470 GLN A 336 CG CD OE1 NE2 REMARK 470 TRP A 337 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 337 CZ3 CH2 REMARK 470 LYS A 347 CG CD CE NZ REMARK 470 ARG A 356 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 358 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 367 CG CD OE1 NE2 REMARK 470 THR A 376 OG1 CG2 REMARK 470 THR A 400 OG1 CG2 REMARK 470 LEU A 422 CG CD1 CD2 REMARK 470 VAL A 423 CG1 CG2 REMARK 470 LYS A 424 CG CD CE NZ REMARK 470 LEU A 425 CG CD1 CD2 REMARK 470 LYS A 431 CG CD CE NZ REMARK 470 ARG A 448 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 451 CG CD CE NZ REMARK 470 ASN A 474 CG OD1 ND2 REMARK 470 ASP A 511 CG OD1 OD2 REMARK 470 LYS A 512 CG CD CE NZ REMARK 470 GLU A 514 CG CD OE1 OE2 REMARK 470 GLU A 516 CG CD OE1 OE2 REMARK 470 ARG B 199 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 315 CG ND1 CD2 CE1 NE2 REMARK 470 VAL B 317 CG1 CG2 REMARK 470 TYR B 318 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 TYR B 319 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 320 CG OD1 OD2 REMARK 470 PRO B 321 CG CD REMARK 470 SER B 322 OG REMARK 470 LYS B 323 CG CD CE NZ REMARK 470 ASP B 324 CG OD1 OD2 REMARK 470 LEU B 325 CG CD1 CD2 REMARK 470 ILE B 326 CG1 CG2 CD1 REMARK 470 GLU B 328 CG CD OE1 OE2 REMARK 470 ILE B 329 CG1 CG2 CD1 REMARK 470 GLN B 330 CG CD OE1 NE2 REMARK 470 LYS B 331 CG CD CE NZ REMARK 470 GLN B 332 CG CD OE1 NE2 REMARK 470 GLN B 334 CG CD OE1 NE2 REMARK 470 GLN B 336 CG CD OE1 NE2 REMARK 470 THR B 338 OG1 CG2 REMARK 470 GLN B 340 CG CD OE1 NE2 REMARK 470 ILE B 341 CG1 CG2 CD1 REMARK 470 GLN B 343 CG CD OE1 NE2 REMARK 470 GLU B 344 CG CD OE1 OE2 REMARK 470 PRO B 345 CG CD REMARK 470 PHE B 346 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 347 CG CD CE NZ REMARK 470 ASN B 348 CG OD1 ND2 REMARK 470 LEU B 349 CG CD1 CD2 REMARK 470 LYS B 350 CG CD CE NZ REMARK 470 THR B 351 OG1 CG2 REMARK 470 LYS B 353 CG CD CE NZ REMARK 470 ARG B 356 CG CD NE CZ NH1 NH2 REMARK 470 MET B 357 CG SD CE REMARK 470 ARG B 358 CG CD NE CZ NH1 NH2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NVP A 557 DBREF 3HVT A 1 556 UNP P03366 POL_HV1B1 599 1154 DBREF 3HVT B 1 428 UNP P03366 POL_HV1B1 599 1026 SEQRES 1 A 556 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 556 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 556 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 556 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 556 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 556 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 556 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 556 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 556 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 556 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 556 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 556 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 556 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 556 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 556 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 556 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 556 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 556 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 556 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 556 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 556 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 556 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 A 556 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 556 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 556 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 556 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 556 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 556 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 556 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 556 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 556 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 556 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 556 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 556 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 556 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 556 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 556 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 556 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 556 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 556 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 556 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 556 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 556 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE SEQRES 1 B 428 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 428 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 428 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 428 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 428 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 428 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 428 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 428 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 428 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 428 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 428 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 428 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 428 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 428 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 428 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 428 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 428 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 428 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 428 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 428 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 428 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 428 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 B 428 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 428 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 428 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 428 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 428 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 428 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 428 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 428 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 428 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 428 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 428 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN HET NVP A 557 20 HETNAM NVP 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2- HETNAM 2 NVP B:2',3'-E][1,4]DIAZEPIN-6-ONE HETSYN NVP NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE FORMUL 3 NVP C15 H14 N4 O HELIX 1 A THR A 27 GLU A 44 1 18 HELIX 2 B ARG A 78 GLN A 85 1 8 HELIX 3 C ASP A 113 VAL A 118 1 6 HELIX 4 D PHE A 124 THR A 128 1 5 HELIX 5 E LYS A 154 GLN A 174 1 21 HELIX 6 F ILE A 195 TRP A 212 1 18 HELIX 7 H THR A 253 SER A 268 1 16 HELIX 8 I VAL A 276 LYS A 281 1 6 HELIX 9 J GLU A 298 LEU A 310 1 13 HELIX 10 K ASP A 364 TRP A 383 1 20 HELIX 11 L LYS A 395 GLU A 404 1 10 HELIX 12 RA ASN A 474 ASP A 488 1 15 HELIX 13 RB GLN A 500 ALA A 508 1 9 HELIX 14 RD GLU A 516 LYS A 527 1 12 HELIX 15 RE GLY A 544 GLY A 555 1 12 HELIX 16 A GLU B 28 GLU B 44 1 17 HELIX 17 B ARG B 78 GLN B 85 1 8 HELIX 18 C GLY B 112 PHE B 116 1 5 HELIX 19 D ASP B 123 THR B 128 1 6 HELIX 20 E LYS B 154 ASN B 175 1 22 HELIX 21 F HIS B 198 TRP B 212 1 15 HELIX 22 H VAL B 254 ILE B 270 1 17 HELIX 23 I ARG B 277 LEU B 282 1 6 HELIX 24 J GLU B 298 LEU B 310 1 13 HELIX 25 K ASP B 364 TRP B 383 1 20 HELIX 26 L LYS B 395 TRP B 401 1 7 SHEET 1 S1 3 ILE A 47 GLY A 51 0 SHEET 2 S1 3 THR A 128 PRO A 133 -1 SHEET 3 S1 3 PRO A 140 TYR A 146 -1 SHEET 1 S2 2 ASN A 57 ILE A 63 0 SHEET 2 S2 2 TRP A 71 ASP A 76 -1 SHEET 1 S3 4 LEU A 214 ASP A 218 0 SHEET 2 S3 4 LYS A 104 GLY A 112 -1 SHEET 3 S3 4 ILE A 178 TYR A 183 -1 SHEET 4 S3 4 ASP A 186 SER A 191 -1 SHEET 1 S4 4 PRO A 226 MET A 230 0 SHEET 2 S4 4 TYR A 232 HIS A 235 -1 SHEET 3 S4 4 LYS A 238 GLN A 242 -1 SHEET 4 S4 4 HIS A 315 TYR A 319 -1 SHEET 1 S5 5 LEU A 349 ALA A 355 0 SHEET 2 S5 5 GLN A 336 TYR A 342 -1 SHEET 3 S5 5 ILE A 326 LYS A 331 -1 SHEET 4 S5 5 PRO A 387 LEU A 391 1 SHEET 5 S5 5 GLU A 413 ASN A 418 1 SHEET 1 S5A 1 ALA A 408 PRO A 412 0 SHEET 1 R1 5 GLY A 462 THR A 470 0 SHEET 2 R1 5 LEU A 452 THR A 459 -1 SHEET 3 R1 5 GLU A 438 ASN A 447 -1 SHEET 4 R1 5 GLU A 492 THR A 497 1 SHEET 5 R1 5 LYS A 530 VAL A 536 1 SHEET 1 S6 3 LYS B 20 TRP B 24 0 SHEET 2 S6 3 THR B 58 LYS B 64 1 SHEET 3 S6 3 TRP B 71 ASP B 76 -1 SHEET 1 S7 3 LYS B 49 PRO B 52 0 SHEET 2 S7 3 ALA B 129 ILE B 132 -1 SHEET 3 S7 3 GLY B 141 TYR B 146 1 SHEET 1 S8 4 THR B 215 PRO B 217 0 SHEET 2 S8 4 SER B 105 ASP B 110 -1 SHEET 3 S8 4 ILE B 178 TYR B 183 -1 SHEET 4 S8 4 ASP B 186 SER B 191 -1 SHEET 1 S9 5 LEU B 349 ALA B 355 0 SHEET 2 S9 5 GLN B 336 TYR B 342 -1 SHEET 3 S9 5 LEU B 325 GLY B 333 -1 SHEET 4 S9 5 PRO B 387 LEU B 391 1 SHEET 5 S9 5 PRO B 412 ASN B 418 1 CISPEP 1 SER B 3 PRO B 4 0 -0.31 CISPEP 2 ILE B 293 PRO B 294 0 0.12 CISPEP 3 THR B 419 PRO B 420 0 -1.03 SITE 1 AC1 10 LEU A 100 LYS A 101 VAL A 106 TYR A 181 SITE 2 AC1 10 TYR A 188 PHE A 227 TRP A 229 LEU A 234 SITE 3 AC1 10 PRO A 236 TYR A 319 CRYST1 223.600 69.900 105.500 90.00 106.40 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004472 0.000000 0.001316 0.00000 SCALE2 0.000000 0.014306 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009881 0.00000